Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3'-5-triiodo-L-thyronine-treated rats.
about
Thyroid Hormone Mediated Modulation of Energy ExpenditureAssessment of mitochondrial energy coupling in vivo by 13C/31P NMR13C and 1H nuclear magnetic resonance study of glycogen futile cycling in strains of the genus FibrobacterDiffering mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose.3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats.Mass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo.Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation.Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.Thyroid hormone action in metabolic regulation.Expression and characterization of a human pyruvate carboxylase variant by retroviral gene transfer.Response to burgess.Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia.Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions.Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA).A computer model of gluconeogenesis and lipid metabolism in the perfused liver.
P2860
Q26801789-398E44DA-CB47-49BD-A108-5E43E1F031F2Q28344306-79BA38A6-8F0D-4F6E-962A-59B88CBD9175Q34070716-19F3AEFC-943E-482D-9145-11E9DC768C9BQ34370865-3E249A08-DC24-463A-9E9E-A44E24639745Q35814769-60A4E447-0E19-4B07-891E-BF0EFCD30084Q35859172-1FCFE8DF-D148-4B94-951C-14FB3CEAF7A7Q36255938-F0AAA055-D64A-4AEA-8F0F-4E3A0B23A4B2Q37051093-266DC976-E60F-4521-A820-097723106A85Q37879999-0D91DF32-3A63-44DE-8FD9-803046A3B812Q38360893-C4719139-2D98-40EE-BF6A-286D876B28F5Q39722345-47E843F7-7333-406A-9F2A-B5AD97C05DFBQ39812091-E1AF4A3C-4225-4D5E-B53D-8601368758FBQ40584025-420C50C1-0E92-4459-9FAA-69AC1F6BD838Q42127633-E83461D8-13DC-4964-A25F-3172ED78F57BQ46970402-C4B42856-A829-4267-A646-863BC5241F5F
P2860
Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3'-5-triiodo-L-thyronine-treated rats.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Substrate cycling between pyru ...... iodo-L-thyronine-treated rats.
@en
Substrate cycling between pyru ...... iodo-L-thyronine-treated rats.
@nl
type
label
Substrate cycling between pyru ...... iodo-L-thyronine-treated rats.
@en
Substrate cycling between pyru ...... iodo-L-thyronine-treated rats.
@nl
prefLabel
Substrate cycling between pyru ...... iodo-L-thyronine-treated rats.
@en
Substrate cycling between pyru ...... iodo-L-thyronine-treated rats.
@nl
P2093
P2860
P1476
Substrate cycling between pyru ...... iiodo-L-thyronine-treated rats
@en
P2093
K F Petersen
P2860
P304
P356
10.1152/AJPENDO.1994.267.2.E273
P407
P433
P577
1994-08-01T00:00:00Z